Full Text View
Tabular View
No Study Results Posted
Related Studies
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
This study has been completed.
Study NCT01167127   Information provided by Mundipharma Pharmaceuticals B.V.

First Received on July 20, 2010.   Last Updated on February 11, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pain
Additional drug interventions recognized in this trial
Naloxone
Oxycodone
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Central Nervous System Agents
Central Nervous System Depressants
Narcotic Antagonists
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Mundipharma Pharmaceuticals B.V.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services